interferon β biosimilar
/ Sudershan Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 28, 2011
Interferon beta in treating patients with metastatic cutaneous melanoma or ocular melanoma
(clinicaltrials.gov)
-
P2, N=21; Completed
Melanoma
March 12, 2011
Permeability assay for treatment response or failure with interferon beta in ms-patients: A novel biomarker?
(AAN 2011)
-
N=13; BBB stabilizing effect of IFN-treatment can also be determined with an in vitro bioassay system and results reflect the clinical course and MRI findings for an individual patient
Multiple Sclerosis
1 to 2
Of
2
Go to page
1